Table 2.
Characteristics of diabetic patients in MHCs and non-MHCs at the start of follow up (T0)
| Patient characteristic* | MHCs (n = 17,045) |
Non MHCs (n = 26,626) |
|---|---|---|
| Age, years, % | ||
| < 45 | 20.7% | 11.5% |
| 45 to 54 | 19.7% | 14.3% |
| 55 to 64 | 21.6% | 20.7% |
| 65 to 74 | 18.6% | 23.2% |
| ≥75 | 19.3% | 30.3% |
| Sex, % male | 41.9% | 43.8% |
| Indigenous status, % | ||
| Indigenous | 11.8% | 5.6% |
| Non-Indigenous | 88.1% | 91.1% |
| Missing | 0.1% | 3.3% |
| Level of social disadvantage | ||
| Most disadvantaged | 15.1% | 10.5% |
| More disadvantaged | 22.7% | 21.1% |
| Little disadvantaged | 24.5% | 23.8% |
| Less disadvantaged | 17.3% | 17.8% |
| Least disadvantaged | 19.0% | 25.8% |
| Missing | 1.3% | 1.0% |
| Residential remoteness | ||
| Metropolitan | 64.8% | 70.9% |
| Rural | 25.0% | 22.7% |
| Remote | 9.8% | 6.3% |
| Missing | 0.4% | 0.1% |
| Charlson comorbidity score, mean (SD) | 0.83 (1.62) | 0.63 (1.43) |
| Diabetes recorded before T0, % | 34.8% | 31.6% |
| Type of treatment at one year, % | ||
| No diabetic medications | 53.1% | 52.5% |
| Oral hypoglycemic agents only | 39.0% | 40.9% |
| Insulin | 7.9% | 6.6% |
| Type of treatment at up to 16 years, % | ||
| No diabetic medications | 33.6% | 32.6% |
| Oral hypoglycemic agents only | 47.7% | 51.0% |
| Insulin | 18.7% | 16.4% |
| Type of mental disorders | ||
| - Alcohol/drug disorders | 8.7% | |
| - Schizophrenia | 4.8% | |
| - Affective psychoses | 18.6% | |
| - Other psychoses | 10.7% | |
| - Neurotic disorders | 17.6% | |
| - Personality disorders | 2.2% | |
| - Adjustment reaction | 5.1% | |
| - Depressive disorder | 4.9% | |
| - Other mental disorders | 5.9% | |
| - Other than mental or behavioural disorders | 21.6% |
Abbreviations: MHCs, mental health clients, SD, standard deviation.
*P < 0.001 for all comparisons.